Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT

[1]  D. Sahani,et al.  Contrast-enhanced MRI of the liver with mangafodipir trisodium: imaging technique and results. , 2002, Journal of computer assisted tomography.

[2]  L. Wagman,et al.  Clinical and Cost Effectiveness of a New Hepatocellular MRI Contrast Agent, Mangafodipir Trisodium, in the Preoperative Assessment of Liver Resectability , 2001, Annals of Surgical Oncology.

[3]  C. Bartolozzi,et al.  Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results , 2001, Abdominal Imaging.

[4]  W F Bennett,et al.  Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: Results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging , 2000, Journal of magnetic resonance imaging : JMRI.

[5]  W. Lees,et al.  Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer , 2000, Diseases of the colon and rectum.

[6]  T. Saclarides,et al.  Liver Resection for Colorectal Cancer: Liver Metastases in the Aged , 2000, The American surgeon.

[7]  T. Murakami,et al.  Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT. , 2000, AJR. American journal of roentgenology.

[8]  G. Frija,et al.  Mechanisms of action of liver contrast agents: impact for clinical use. , 1999, Journal of computer assisted tomography.

[9]  R. Semelka,et al.  Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. , 1999, Radiology.

[10]  N. Heaton,et al.  MnDPDP-enhanced MR imaging of the liver , 1997, Acta radiologica.

[11]  B. V. Van Beers,et al.  Contrast-enhanced MR imaging of the liver. , 1997, Radiology.

[12]  M. Taupitz,et al.  Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging? , 1997, Radiology.

[13]  B. V. Van Beers,et al.  Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. , 1996, Radiology.

[14]  B. Marincek,et al.  Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. , 1995, Radiology.

[15]  D. Khayat,et al.  Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. , 1994, Radiology.

[16]  V. Servois,et al.  Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25. , 1994, Radiology.

[17]  R. Semelka,et al.  Solitary hepatic metastasis: Comparison of dynamic contrast‐enhanced CT and MR imaging with fat‐suppressed T2‐weighted, Breath‐hold T1‐weighted FLASH, and dynamic gadolinium‐enhanced FLASH sequences , 1994, Journal of magnetic resonance imaging : JMRI.

[18]  T K Foo,et al.  Abdominal MR imaging: comparison of T2-weighted fast and conventional spin-echo, and contrast-enhanced fast multiplanar spoiled gradient-recalled imaging. , 1993, Radiology.

[19]  D. Elias,et al.  MRI of Liver Metastases from Colorectal Cancer vs. CT during Arterial Portography , 1993, Journal of computer assisted tomography.

[20]  G. Dodd,et al.  Hepatic parenchymal perfusion defects detected with CTAP: imaging-pathologic correlation. , 1992, Radiology.

[21]  D. Elias,et al.  Detection of liver metastases from colorectal cancer: comparison of intraoperative US and CT during arterial portography. , 1992, Radiology.

[22]  P. Sugarbaker.  Surgical decision making for large bowel cancer metastatic to the liver. , 1990, Radiology.

[23]  A. Baert,et al.  Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T. , 1989, AJR. American journal of roentgenology.

[24]  B. Hamm,et al.  Imaging of metastases to the liver , 2004, European Radiology.

[25]  Richard Stang,et al.  Resection of colorectal liver metastases , 1997, Journal of Gastrointestinal Surgery.

[26]  E. Rummeny,et al.  MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool , 2002, European Radiology.

[27]  C. Bartolozzi,et al.  MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis , 2000, European Radiology.

[28]  G. Fuhrman,et al.  Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. , 2000, Annals of surgery.

[29]  C. Bartolozzi,et al.  Abdominal MR: liver and pancreas , 1999, European Radiology.

[30]  A. Rahmouni,et al.  Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging , 1999, European Radiology.

[31]  K. Engelmann,et al.  Liver metastases: interventional therapeutic techniques and results, state of the art , 1999, European Radiology.

[32]  C. Bartolozzi,et al.  Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography , 1998, Magnetic Resonance Materials in Physics, Biology and Medicine.